Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael R Shurin

Showing results (1-10 of 139) with videos related to

Pageof 14
Sort By:
Nature Medicine|January 9, 2013
Dual role of immunomodulation by anticancer chemotherapyMichael R Shurin
Immunotargets and Therapy|July 30, 2016
Cancer as an immune-mediated diseaseMichael R Shurin
Cell Cycle (Georgetown, Tex.)|November 20, 2010
MicroRNAs are invading the tumor microenvironment: Fibroblast microRNAs regulate tumor cell motility and invasivenessMichael R Shurin
Idrugs : the Investigational Drugs Journal|October 31, 2007
Immune-mediated diseases: from theory to therapy. 10-15 September 2007, Moscow, RussiaMichael R Shurin
The Journal of Clinical Investigation|November 6, 2018
Osteopontin controls immunosuppression in the tumor microenvironmentMichael R Shurin
Immunotargets and Therapy|December 13, 2018
Immunological targets for cancer therapy: new recognitionMichael R Shurin
Methods in Molecular Biology (Clifton, N.J.)|January 7, 2003
Preparation of human dendritic cells for tumor vaccinationMichael R Shurin
Advances in Experimental Medicine and Biology|December 25, 2017
Targeting Myeloid-Derived Suppressor Cells in CancerWaseem Anani, Michael R Shurin
The Journal of Clinical Investigation|May 2, 2022
Cross-talk between HIF and PD-1/PD-L1 pathways in carcinogenesis and therapyMichael R Shurin, Viktor Umansky
Future Oncology (London, England)|October 4, 2012
Cancer and infection: friends or foes?Nahed Ismail, Michael R Shurin
Pageof 14

Showing results (1-10 of 139) with videos related to

Sort By:
Pageof 14
Nature Medicine|January 9, 2013
Dual role of immunomodulation by anticancer chemotherapyMichael R Shurin
Immunotargets and Therapy|July 30, 2016
Cancer as an immune-mediated diseaseMichael R Shurin
Cell Cycle (Georgetown, Tex.)|November 20, 2010
MicroRNAs are invading the tumor microenvironment: Fibroblast microRNAs regulate tumor cell motility and invasivenessMichael R Shurin
Idrugs : the Investigational Drugs Journal|October 31, 2007
Immune-mediated diseases: from theory to therapy. 10-15 September 2007, Moscow, RussiaMichael R Shurin
The Journal of Clinical Investigation|November 6, 2018
Osteopontin controls immunosuppression in the tumor microenvironmentMichael R Shurin
Immunotargets and Therapy|December 13, 2018
Immunological targets for cancer therapy: new recognitionMichael R Shurin
Methods in Molecular Biology (Clifton, N.J.)|January 7, 2003
Preparation of human dendritic cells for tumor vaccinationMichael R Shurin
Advances in Experimental Medicine and Biology|December 25, 2017
Targeting Myeloid-Derived Suppressor Cells in CancerWaseem Anani, Michael R Shurin
The Journal of Clinical Investigation|May 2, 2022
Cross-talk between HIF and PD-1/PD-L1 pathways in carcinogenesis and therapyMichael R Shurin, Viktor Umansky
Future Oncology (London, England)|October 4, 2012
Cancer and infection: friends or foes?Nahed Ismail, Michael R Shurin
Pageof 14